BioMarin Announces First Quarter 2020 Total Revenue Growth of 25% to $502 million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. RXRX

Go back to BioMarin Announces First Quarter 2020 Total Revenue Growth of 25% to $502 million

BioMarin Pharma (BMRN) Tops Q1 EPS by 39c, Revs Beat; Trims FY Rev Outlook

April 29, 2020 4:03 PM EDT

BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $0.44, $0.39 better than the analyst estimate of $0.05. Revenue for the quarter came in at $502.1 million versus the consensus estimate of $468.77 million.

GUIDANCE:

BioMarin Pharma sees FY2020 revenue of $1.85-1.95 billion, versus prior of... More